Patents by Inventor Michael Patrick Kelly

Michael Patrick Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190008794
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 10, 2019
    Applicant: HKL Medical, LLC
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Publication number: 20190008793
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 10, 2019
    Applicant: HKL Medical, LLC
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Publication number: 20190000772
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: September 11, 2018
    Publication date: January 3, 2019
    Applicant: HKL Medical, LLC
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Publication number: 20190000771
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Applicant: HKL Medical, LLC
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Publication number: 20180344659
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Applicant: HKL Medical, LLC
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Publication number: 20180221296
    Abstract: A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over traditional routes of administration. A novel method of dosing IS medications based on wound surface area provides the parameters for safe and effective dosing, a necessary advance for any FDA approval. Large IS doses increase risk of toxicity from impurities allowed in drugs given by other routes. Methods are presented for ultrapurification, particularly of endotoxins. Methods are presented for sterile delivery to the wound, to prevent aerosolization, and to homogenize application. Pharmacodynamic parameters make certain drugs advantageous as IS agents, including slow trans-wound surface diffusion, protein binding, and limited local tissue toxicity. Vancomycin is a prototypical drug with these features and is therefore very useful as an IS medication.
    Type: Application
    Filed: February 8, 2018
    Publication date: August 9, 2018
    Inventors: Terrence Fletcher Holekamp, Lawrence Gerard Lenke, Michael Patrick Kelly
  • Patent number: 6142229
    Abstract: A method and system for producing hydrocarbons from a low permeability formation through a well wherein the formation is first fractured with steam. The pressure of the produced fluids is measured at timed intervals and signals representative of these measurements are inputted into a computer which, in turn, calculates the rate of change in the pressure and compares this rate to a preferred limit of rate change. When the limit is exceeded, the computer outputs a signal to adjust a control value in the production line to keep the rate of pressure decrease within the preferred limit. When production drops below a certain level, the control valve is fully opened to "bump" the well and allow the pressure to increase to a new maximum. This new maximum pressure is then used to set a new preferred limit of pressure rate change.
    Type: Grant
    Filed: September 16, 1998
    Date of Patent: November 7, 2000
    Assignee: Atlantic Richfield Company
    Inventors: Aubrey G. Branson, Jr., Michael Patrick Kelly, Robert S. Swain